EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer of the cervix uteri: 2025 update

Neerja Bhatla iD, Daisuke Aoki, Daya Nand Sharma, Rengaswamy Sankaranarayanan

International Journal of Gynecology & Obstetrics · 2025-09 · 171 (S1) · 87-108

DOI: 10.1002/ijgo.70277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 04.09.2025. Verfasst von Neerja Bhatla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the publication of the 2021 FIGO Cancer Report, there has been further progress in the global effort to attain the WHO goal of cervical cancer elimination using a three‐pillar approach of vaccination, screening, and treatment. The HPV vaccination is now included in the national program of over 140 countries. Two‐dose schedules are being implemented in 80 countries and one‐dose schedules in 60 countries. Screening has seen major advances with the wider implementation of HPV testing, including the option of self‐sampling, portable screening and treatment devices, and the incorporation of artificial intelligence. Diagnostic accuracy is being enhanced with immunohistochemistry and receptor assays. Surgical treatment of invasive cancer is being revolutionized with the possibility of conservative surgery in very early stages, minimizing complications and adverse effects and offering feasibility of fertility sparing. New data on minimally invasive surgery are redefining the role of laparoscopy and robotic surgery in early stages with small tumor size. Sentinel lymph node evaluation is an emerging alternative to complete lymphadenectomy. Immunotherapy has opened up new possibilities for the management of recurrent and metastatic disease. This chapter discusses the management of cervical cancer based on the stage of disease, including attention to palliation and quality‐of‐life issues, with insights into the results from recent landmark trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHumansFemalePapillomavirus VaccinesNeoplasm StagingQuality of LifePapillomavirus InfectionsEarly Detection of Cancer

Stichwörter der Autor:innen

FIGO Cancer ReportHPV vaccinationcancercerviximmunotherapyradiationscreeningstagingsurgery

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
  • Division of Preventive Medical Center, Akasaka Sanno Medical Center, Tokyo, Japan.
  • International University of Health and Welfare Graduate School, Tokyo, Japan.
  • Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Division of Preventive Oncology, Karkinos Healthcare, Kerala Operations, Ernakulam, India.

ORCID-Profile: Neerja Bhatla

Zitieren

APA

Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2025). Cancer of the cervix uteri: 2025 update. International Journal of Gynecology & Obstetrics, 171(S1), 87-108. https://doi.org/10.1002/ijgo.70277

Vancouver

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2025 update. International Journal of Gynecology & Obstetrics. 2025;171(S1):87-108. doi:10.1002/ijgo.70277

BibTeX
@article{Bhatla2025,
  author = {Bhatla, Neerja and Aoki, Daisuke and Sharma, Daya Nand and Sankaranarayanan, Rengaswamy},
  title = {Cancer of the cervix uteri: 2025 update},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {171},
  number = {S1},
  pages = {87--108},
  doi = {10.1002/ijgo.70277}
}
Kostenlos starten →